comparemela.com

Latest Breaking News On - Edesa biotech inc - Page 14 : comparemela.com

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Edesa Biotech Secures $10 Million Credit Facility with Company Founder
torontotelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontotelegraph.com Daily Mail and Mail on Sunday newspapers.

Canada
United-kingdom
Toronto
Ontario
British
Gary-koppenjan
Stephen-lemieux
Linkedin
Nasdaq
Twitter
British-columbia-securities-commission
Edesa-biotech-inc

Edesa Biotech Announces One-for-Seven Reverse Share Split

Edesa Biotech Announces One-for-Seven Reverse Share Split
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Toronto
Ontario
Canada
United-kingdom
British
Gary-koppenjan
Linkedin
Computershare-investor-services-inc
Exchange-commission
British-columbia-securities-commission
Edesa-biotech-inc
Twitter

EDSA Stock Price | Edesa Biotech Inc. Stock Quote (U.S.: Nasdaq)

EDSA | Complete Edesa Biotech Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Canada
Canadian
Etby-ciara-linnane
Nasdaq
Edesa-biotech-inc
Edesa-biotech
Redsa
Dsa-analyst-estimates
Dsa-earnings-estimates
Dsa-share-estimates
Dsa-analyst-recommendations
Dsa-ratings

Edesa Biotech (NASDAQ:EDSA) Stock Price Down 0.9%

Edesa Biotech, Inc. (NASDAQ:EDSA – Get Free Report) shares fell 0.9% during mid-day trading on Thursday . The company traded as low as $0.60 and last traded at $0.63. 39,653 shares changed hands during mid-day trading, a decline of 66% from the average session volume of 117,178 shares. The stock had previously closed at $0.63. […]

Edesa-biotech-company-profile
Renaissance-technologies
Millennium-management
Cibc-world-market-inc
Cm-management
Edesa-biotech-inc
Nasdaq
Edesa-biotech
Get-free-report
World-market
Edesa-biotech-daily

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

TORONTO - Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced the preprint publication of favorable data from a Phase 2.

Toronto
Ontario
Canada
United-kingdom
British
Gary-koppenjan
British-columbia-securities-commission
Exchange-commission
Drug-administration
Securities-exchange
Nasdaq
Edesa-biotech-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.